Human Medicines: Highlights of 2017

The European Medicines Agency has published an overview of its key recommendations of 2017 regarding the authorisation of new medicines and the safety monitoring of medicines. EMA hasrecommended 92 medicines for marketing authorisation in 2017. Of these, 35 had a new active substance, which have never been authorised in the European Union before.